TrueTicker

NIFTY 500 › Healthcare

Healthcare · NIFTY 500

Rubicon Research Ltd.

RUBICON on NSE · 19 Nov 2026

NIFTY 500

1,722.30 ▲ +3.86 % on the day

Overview Technical Risk & rank Results Accounts Filings Guidance & governance

Guidance tracker

What RUBICON guided, and what came next

FiledWhat the filing saysNext results: profit YoYRevenueMove on the day
12 Nov 2026Rubicon Research Limited filed the transcript of its Q2 FY2026-27 earnings conference call held on November 5, 2026. Management (CEO Parag Sancheti) said Q2 revenue from operations was INR576 crores versus INR412 crores a year earlier, and PAT was INR90 crores versus INR54 crores; operating EBITDA was INR144 crores... NSE copy No results filed since
19 Aug 2026Rubicon Research filed the transcript of its Q1 FY27 earnings conference call held on August 14, 2026. Management reported Q1 revenue from operations of INR534 crores (up 51% year-on-year), EBITDA of INR131 crores (up 65%) and PAT of about INR85 crores (up more than 95%), with PAT including a one-off insurance... NSE copy +68.0 %+39.9 %-4.7 %
02 Jun 2026Rubicon Research filed the transcript of its Q4 FY26 earnings call held on May 29, 2026. Management reported Q4 FY26 revenue of INR 5,140 million (up 44% year-on-year), operating EBITDA of INR 1,190 million (up 64%) and PAT of INR 768 million (up 112%); full-year revenue was INR 17,540 million (up 37%) and PAT was... NSE copy +95.8 %+51.6 %+11.1 %
06 Feb 2026Rubicon Research filed the transcript of its Q3 FY2025-26 earnings conference call held on February 3, 2026. Management reported Q3 revenue from operations of INR 476 crores (up 52% YoY), EBITDA of INR 112 crores (up 59%), PAT of INR 73 crores (up 91%) and EPS of INR 4.41. CFO Nitin Jajodia said 9M revenue was INR... NSE copy --+16.5 %
18 Nov 2025Rubicon Research filed the transcript of its Q2 FY 2025-26 earnings conference call held on 13 November 2025. Management said revenue grew 39% year-on-year, operating EBITDA grew 53%, and PAT was 56% higher than the previous year, with annualized ROACE of 36% for the quarter (CEO Parag Sancheti). CFO Nitin Jajodia... NSE copy --+7.2 %
13 Nov 2025Rubicon Research Limited filed its Investor Presentation dated 13 November 2025 for the quarter and half year ended 30 September 2025 (Q2 FY26). Q2 FY26 operating revenue was ₹4,120 millions, up 39.2% YoY from ₹2,960 millions; operating EBITDA was ₹943 millions (up 52.9% from ₹617 millions); PAT was ₹539 millions... NSE copy --+7.2 %

Filings tagged as guidance, newest first (6 in all), with the company's next results after each: profit and revenue against the same quarter a year before, and the share's move on the results day. Whether the guidance was met is for the reader to judge from both; the site does not score it. The summaries are written by an AI model from the filing and can be wrong - the filing is the source.

Governance

Management, auditors, ratings and legal matters

FiledKindWhat the filing says
12 Nov 2026Legal or regulatoryRubicon Research Limited filed the transcript of its Q2 FY2026-27 earnings conference call held on November 5, 2026. Management (CEO Parag Sancheti) said Q2 revenue from operations was INR576 crores versus INR412 crores a year earlier, and PAT was INR90 crores versus INR54 crores; operating EBITDA was INR144 crores... NSE copy
19 Aug 2026Legal or regulatoryRubicon Research filed the transcript of its Q1 FY27 earnings conference call held on August 14, 2026. Management reported Q1 revenue from operations of INR534 crores (up 51% year-on-year), EBITDA of INR131 crores (up 65%) and PAT of about INR85 crores (up more than 95%), with PAT including a one-off insurance... NSE copy
20 Jul 2026Legal or regulatoryBoard of Rubicon Research Limited, at its meeting held July 20, 2026, fixed the 27th AGM for Wednesday, August 26, 2026, through video conferencing or other audio-visual means. The Board fixed Friday, August 7, 2026 as the record date for final dividend of ₹1.50 per equity share (face value ₹1 each) for FY 2025-26,... NSE copy
03 Feb 2026Legal or regulatory, Management changeRubicon Research Limited filed the outcome of its board meeting held on February 3, 2026 (meeting ran from 3:00 PM to 4:30 PM IST). The board approved the appointment of Dr. Pradnya Saravade as Additional Independent Woman Director for three years, from February 3, 2026 to February 2, 2029, subject to shareholder... NSE copy
03 Feb 2026Legal or regulatoryRubicon Research Limited's board approved the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025, at a meeting held February 3, 2026 (3:00 PM to 4:30 PM IST). The filing encloses the results and the statutory auditor's limited review report, which states... NSE copy

Filings with a management change, a legal or regulatory matter or a credit rating (by their tags), or naming an auditor, a resignation or a pledge of shares; newest first (5 in all). A list of what was filed, not a judgement of the company.

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in